Clinical Trials Directory

Trials / Unknown

UnknownNCT06237569

Dose Low Dose Ketamine in Casesarian

Effects of Low Dose ketamıne on Postpartum Depression During Caesarean Sections

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Inonu University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The results of ketamine, ketamine and midazolom and placebo can be copied after birth in cesareans subjected to spinal anesthesia.

Detailed description

Postpartum depression will be evaluated by dividing the patients into 3 groups: group 1 as ketamine, group 2 as ketamine and midasom, and group 3 as placebo group.

Conditions

Interventions

TypeNameDescription
DRUGApplication of ketamine and midazolam or ketamine alone to patients undergoing cesarean section under spinal anesthesiaA single dose of 0.5 mg/kg IV diluted to 5 ml with 0.9% saline was planned to be administered simultaneously to the Ketamine Group (GROUP 1), ketamine and midazolam within 5 minutes after the newborn umbilical cord was clamped (Group 2). After midazolam 0.03 mg/kg is given, a single dose IV bolus of 0.5 mg/kg diluted to 5 ml with 0.9% saline will be administered. Patients experience dizziness, hallucinations, nausea, headache, vomiting, diplopia and blurred vision, the time until the first analgesic request; Depression parameters will be evaluated with the Edinburgh Postpartum Depression Scale (EPDS) in all patients before cesarean section and at the 1st, 2nd and 4th weeks after birth.

Timeline

Start date
2024-06-01
Primary completion
2024-08-01
Completion
2024-09-01
First posted
2024-02-01
Last updated
2024-02-01

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06237569. Inclusion in this directory is not an endorsement.